Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study
| Image |  |
|---|---|
| Description | scientific article published on 31 March 2019 |
| Author/s |
author: Jacob P Laubach Philippe Moreau Francesca Gay Torben Plesner Paul G. Richardson Monique C Minnema |
| Publication date | March 31, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |